A Phase 3 trial enrolling ~800 people for an 89-week study, where obese adults will be using either Retatrutide or Tirzepatide to see which peptide comes out as the winner A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943 A Phase 1 trial enrolling ~74 obese adults for a 6-month study, where Retatrutide will be examined for its effects on energy intake, energy expenditure and appetite when compared against a placebo A Phase 2 trial enrolling ~120 people for a 31-week study, where obese/overweight adults with chronic kidney disease (CKD) and/or Type 2 Diabetes will use Retatrutide to assess its effects on renal function The Best Retatrutide Dose For Maximal Fat Loss, Appetite Suppression, And Lean Muscle Preservation Ive kept you waiting long enough with all the boring science mumbo-jumbo
Week 2: Add low-carb tortillas
Hepatology 55 , 19421953 (2012)
Studies show over 3 to 6 months, many people lose 1020% of their starting body weight, depending on dose, consistency, and individual factors
Common side effects include nausea, vomiting, and gastrointestinal distressusually transient and dose-dependent